UNC5B and pancreatic ductal adenocarcinoma: One study has shown that the knockdown of UNC5B antisense lncRNA 1 (UNC5B-AS1) significantly inhibits the glycolysis of pancreatic ductal adenocarcinoma cells carrying KRAS mutations [49].